PBE ETF

$80.22
Screen 3,400+ ETFsFind similar ETFs with lower fees

Returns Overview

1 Month
+0.11%
3 Months
-1.14%
6 Months
+20.79%
YTD
-0.43%
1 Year
+24.22%
3 Years
+9.25%
5 Years
+2.26%
10 Years
+8.57%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would PBE have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+0.11%

3 Months Performance

-1.14%

6 Months Performance

+20.79%

1 Year Performance

+24.22%

Benchmark & Peers

Benchmark
Dynamic Biotechnology & Genome Intellidex Index(^DZO)
This ETF (YTD)
-0.43%
Peer Avg (YTD)
+1.55%
vs Peers
-1.98%

PBE ETF Performance

PBE performance across multiple time periods: 1-month 0.11%, YTD -0.43%, 1-year 24.22%, 3-year 9.25%, 5-year 2.26%, 10-year 8.57%.

PBE returns trail the peer average of 1.55% YTD. With an expense ratio of 0.58%, investors should weigh costs against performance when evaluating this ETF.

PBE performance comparison shows side-by-side returns with another fund. PBE alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+0.11%N/A
3 Months-1.14%N/A
6 Months+20.79%N/A
1 Year+24.22%N/A
3 Years+9.25%N/A
5 Years+2.26%N/A

All returns shown are total returns, not annualized